NCT06627387

Brief Summary

The goal of this clinical trial is to assess the Usability, adherence, acceptance, and security of an augmented reality platform for balance training in patients with balance disorders due to degenerative injuries or cerebrovascular diseases. The main questions it aims to answer are:

  • Is the augmented reality system usable, acceptable, and safe with good adherence?
  • Does the system improve the balance in our population?
  • Participants will be asked to assist at Vall d'Hebrón Hospital, where patients will undergo balance training under the supervision of a physiotherapist three days a week for four weeks.
  • If the patients meet the inclusion criteria, the intervention will be extended for two more weeks at home.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 6, 2024

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 20, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 4, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

October 4, 2024

Status Verified

October 1, 2024

Enrollment Period

6 months

First QC Date

August 20, 2024

Last Update Submit

October 2, 2024

Conditions

Keywords

Augmented RealityPostural balanceNeurological Rehabilitation

Outcome Measures

Primary Outcomes (6)

  • System Usability Scale (SUS)

    The System Usability Scale is a reliable tool for measuring usability. It consists of a 10-item questionnaire with five response options for respondents, from Strongly Agree to Disagree Strongly. A value above 68 points is considered acceptable.

    "Week 4" "Week 6"

  • Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0)

    The instrument is a self-administered questionnaire assessing user satisfaction with assistive technology product and associated services.

    "Week 4" "Week 6"

  • User Esperience Questionnaire (UEQ)

    The scales of the questionnaire cover comprehensive impression of user experience. Both classical usability aspects (efficiency, perspicuity, dependability) and user experience (originality stimulation) are measured. The items are scaled from -3 to +3. Thus, -3 represents the most negative answer, 0 a neutral answer, and +3 the most positive answer.

    "Week 4" "Week 6"

  • Adherence (Home)

    Time the Augmentad reality system is used in comparision to the scheduled dosage.

    "Week 6"

  • Adherence (Hospital)

    Total sessions scheduled for therapy compared to the number of sessions attended

    "Week 4"

  • Ad-hoc questions

    Questions to assess the attitude towards the system and to gather data on privacy and feeling of stigma.

    "Day 0" "Week 4" "Week 6"

Secondary Outcomes (5)

  • Berg Balance Scale

    "Day 0" "Week 4" "Week 6"

  • Postural Sway

    "Day 0" "Week 4" "Week 6"

  • Five Times Sit to Stand Test (FTSS)

    "Day 0" "Week 4" "Week 6"

  • The Activities-specific Balance Confidence (ABC) Scale.

    "Day 0" "Week 4" "Week 6"

  • The EuroQol-5 Dimension-5 Level (EQ-5D-5L)

    "Day 0" "Week 4" "Week 6"

Other Outcomes (1)

  • The Montreal Cognitive Assesment (MoCA)

    "Day 0"

Study Arms (1)

Balance training

EXPERIMENTAL

The intervention will be carried out in two phases. The first phase will take place at Vall d'Hebron Hospital, where patients will undergo balance training under the supervision of a physiotherapist. The scheduled dose will be 60 minutes a day, 3 days a week for 4 weeks. If the patients meet the inclusion criteria, the intervention will be extended for two more weeks at home.

Other: Balance Training Using Augmented Reality

Interventions

The intervention will be carried out in two phases. The first phase will take place at Vall d\'Hebron Hospital, where patients will undergo balance training under the supervision of a physiotherapist. The scheduled dose will be 60 minutes daily, three days a week for four weeks. If the patients meet the inclusion criteria, the intervention will be extended for two more weeks at home. For this task, the involvement of a family member as a training partner will be essential. Relatives will receive training on using the system in the hospital and must be present whenever the patient undergoes the training at home. Three assessments will be carried out during the six weeks of the study. At the beginning of the intervention ("Day 0" ), a second is once the hospital intervention has been carried out ("Week 4" ), and the last is once the home intervention has been carried out ("Week 6").

Also known as: Personalized Health Assistance SystEM (PHASE)
Balance training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Balance impairment due cerebrovascular diseases or neurodegenerative diseases.
  • Being able to mantain standing for 2 minuts without assistance.
  • Berg scale ≥21
  • Age ≥18
  • Signing informed consent
  • To have a training partner during the exercises at home.
  • No fall attempt during hospital intervention
  • No have enough space to train safely at their home.
  • Being familiar with technological devices such a laptop, tablets or inteligent cellphones.

You may not qualify if:

  • The presence of a condition or abnormality that could compromise the patient's safety.
  • Severe cognitive impairments tha prevent the execution of the xperiment (MoCA \<19)
  • Presence of sensory aphasia.
  • Diagnostic of conduct disorders.
  • Presence of severe neglect.
  • Spasticity =4 in MAS lower limb.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Vall D'Hebrón

Barcelona, Barcelona, 08035, Spain

RECRUITING

Related Publications (5)

  • Truijen S, Abdullahi A, Bijsterbosch D, van Zoest E, Conijn M, Wang Y, Struyf N, Saeys W. Effect of home-based virtual reality training and telerehabilitation on balance in individuals with Parkinson disease, multiple sclerosis, and stroke: a systematic review and meta-analysis. Neurol Sci. 2022 May;43(5):2995-3006. doi: 10.1007/s10072-021-05855-2. Epub 2022 Feb 17.

    PMID: 35175439BACKGROUND
  • Lim JH, Lee HS, Song CS. Home-based rehabilitation programs on postural balance, walking, and quality of life in patients with stroke: A single-blind, randomized controlled trial. Medicine (Baltimore). 2021 Sep 3;100(35):e27154. doi: 10.1097/MD.0000000000027154.

    PMID: 34477171BACKGROUND
  • Keller JL, Bastian AJ. A home balance exercise program improves walking in people with cerebellar ataxia. Neurorehabil Neural Repair. 2014 Oct;28(8):770-8. doi: 10.1177/1545968314522350. Epub 2014 Feb 13.

    PMID: 24526707BACKGROUND
  • Lei C, Sunzi K, Dai F, Liu X, Wang Y, Zhang B, He L, Ju M. Effects of virtual reality rehabilitation training on gait and balance in patients with Parkinson's disease: A systematic review. PLoS One. 2019 Nov 7;14(11):e0224819. doi: 10.1371/journal.pone.0224819. eCollection 2019.

    PMID: 31697777BACKGROUND
  • Iruthayarajah J, McIntyre A, Cotoi A, Macaluso S, Teasell R. The use of virtual reality for balance among individuals with chronic stroke: a systematic review and meta-analysis. Top Stroke Rehabil. 2017 Jan;24(1):68-79. doi: 10.1080/10749357.2016.1192361. Epub 2016 Jun 16.

    PMID: 27309680BACKGROUND

MeSH Terms

Conditions

Cerebrovascular DisordersNeurodegenerative Diseases

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Susana Rodriguez Gonzalez, MD

    VHIR

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Susana Rodriguez Gonzalez, MD

CONTACT

Marta Fernandez-Lobera, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: usability study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2024

First Posted

October 4, 2024

Study Start

August 6, 2024

Primary Completion

January 31, 2025

Study Completion

March 31, 2025

Last Updated

October 4, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

We are the only center involved in the studdy and we don\&#39;t consider to share patients data with other researchers.

Locations